Beacon Capital Management »

Black Diamond Therapeutics shares owned by Beacon Capital Management

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Beacon Capital Management from 13F filings

Historical chart of Beacon Capital Management investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Beacon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Beacon Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $45k 16k 2.87
2023-09-30 $79k 16k 5.05
2023-06-30 $79k 16k 5.05
2023-03-31 $67k 36k 1.89
2022-12-31 $64k 36k 1.80
2022-09-30 $88k 36k 2.47
2022-06-30 $66k 24k 2.75
2022-03-31 $66k 24k 2.75